Question 1

What are the potential benefits of participating in this trial for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma clinical trial (NCT00289640). Contact the study team or your healthcare provider for specific answers.

Question 2

How does ipilimumab compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma clinical trial (NCT00289640). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma clinical trial (NCT00289640). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma clinical trial (NCT00289640). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if the treatment does not work for me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma clinical trial (NCT00289640). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma clinical trial (NCT00289640). Contact the study team or your healthcare provider for specific answers.

What this study is about